Recent Interviews
Events
DATABASE UPDATES
- DATATRAK International United States | Global eClinical solutions for the clinical trials industry
- Fibrocell Science | Develops personalized cell therapies for aesthetic, medical, and scientific...
- Rubigo Therapeutics United States | Delivery of skin cancer treatment Imiquimod through improved delivery...
- Gynesonics Redwood City, CA 94063 | Gynesonics, Inc is a medical device company committed to...
- NanoViricides, Inc. West Haven, CT | Anti-viral drugs to fight HIV, influenza, and other infections
- Nanobiotix France | Non-invasive nanoparticle-based cancer therapy
- Rib-X Pharmaceuticals | New antibiotics for Serious Drug Resistant Infections
NEWS
January 26 2012
Advaxis is a clinical-stage biotechnology company developing the next generation of immunotherapies.
S.E.A. Medical Secures $3 Million in Series B Financing from JK&B Capital
January 26 2012
Healthtech company makes strides towards developing medical devices designed to catch life-threatening IV drug errors before they harm patients
Provectus Receives Guidance From FDA On Pathway to Approval for Phase 3 Trial of PV-10 For Metastatic Melanoma
January 25 2012
Dr. Craig Dees talks candidly in a live audio interview about the company’s developments.
This Week In Diagnostics
January 24 2012
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
Partners & Sponsors









